GPEx® Lightning is built upon Catalent’s existing GPEx cell line development technology, which is an established means of generating genetically stable, high-titer cell lines.

Leveraging the GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx Lightning combines innovative solutions, including a novel gene insertion technology, to further shorten drug substance development by up to three months compared to previous timelines.

URL: https://biologics.catalent.com/biologics/drug-substance/cell-line-development/

Catalent
14 Schoolhouse Road Somerset, NJ 08873
Telephone: +1 888 765 8846
solutions@catalent.com
www.catalent.com

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777